- Q1 2024 Koninklijke Philips NV Earnings Call TranscriptApr 29, 2024€25.62 (+37.56%)Earnings
- Q4 2023 Koninklijke Philips NV Earnings Call TranscriptJan 29, 2024€19.28 (-3.93%)Earnings
- Q3 2023 Koninklijke Philips NV Earnings Call TranscriptOct 23, 2023€16.29 (-2.40%)Earnings
- Q2 2023 Koninklijke Philips NV Earnings Call TranscriptJul 24, 2023€20.12Earnings
- Koninklijke Philips NV Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call TranscriptMay 16, 2023
- Q1 2023 Koninklijke Philips NV Earnings Call TranscriptApr 24, 2023€15.66Earnings
- Q4 2022 Koninklijke Philips NV Earnings Call TranscriptJan 30, 2023€14.27Earnings
- Koninklijke Philips NV to Discuss Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call TranscriptDec 21, 2022
- Q3 2022 Koninklijke Philips NV Earnings Call TranscriptOct 24, 2022€12.05 (-1.71%)Earnings
- Koninklijke Philips NV Provides Update on Its Financial Performance in Q3 2022 and Full-year Outlook Call TranscriptOct 12, 2022
- Q2 2022 Koninklijke Philips NV Earnings Call TranscriptJul 25, 2022€20.12Earnings
- Koninklijke Philips NV Provides Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call TranscriptJun 28, 2022
- Koninklijke Philips NV Annual Shareholders Meeting TranscriptMay 10, 2022
- Q1 2022 Koninklijke Philips NV Earnings Call TranscriptApr 25, 2022€23.08 (-12.59%)Earnings
- Q4 2021 Koninklijke Philips NV Earnings Call TranscriptJan 24, 2022€25.99 (-4.46%)Earnings
- Preliminary Q4 2021 Koninklijke Philips NV Earnings Call TranscriptJan 12, 2022€26.57 (-15.17%)Earnings
- Q3 2021 Koninklijke Philips NV Earnings Call TranscriptOct 18, 2021€34.53 (-2.85%)Earnings
- Q2 2021 Koninklijke Philips NV Earnings Call TranscriptJul 26, 2021€36.21 (-4.06%)Earnings
- Koninklijke Philips NV Annual Shareholders Meeting TranscriptMay 06, 2021
- Q1 2021 Koninklijke Philips NV Earnings Call TranscriptApr 26, 2021€44.88 (-3.56%)Earnings
- Q4 2020 Koninklijke Philips NV Earnings Call TranscriptJan 25, 2021€43.43 (+4.24%)Earnings
- Koninklijke Philips NV to Acquire BioTelemetry Inc Call TranscriptDec 18, 2020
- Koninklijke Philips NV Virtual Capital Markets Day TranscriptNov 06, 2020
- Q3 2020 Koninklijke Philips NV Earnings Call TranscriptOct 19, 2020€39.49 (+2.56%)Earnings
- Q2 2020 Koninklijke Philips NV Earnings Call TranscriptJul 20, 2020€42.35 (+5.08%)Earnings
- Koninklijke Philips NV Extraordinary Shareholders Meeting TranscriptJun 26, 2020
- Koninklijke Philips NV Annual Shareholders Meeting TranscriptApr 30, 2020
- Q1 2020 Koninklijke Philips NV Earnings Call TranscriptApr 20, 2020€36.17 (+6.75%)Earnings
- Q4 2019 Koninklijke Philips NV Earnings Call TranscriptJan 28, 2020€39.31 (-2.16%)Earnings
- Q3 2019 Koninklijke Philips NV Earnings Call TranscriptOct 28, 2019€35.6 (-0.75%)Earnings
- Preliminary Q3 2019 Koninklijke Philips NV Earnings Call TranscriptOct 10, 2019€34.39 (-9.18%)Earnings
- Q2 2019 Koninklijke Philips NV Earnings Call TranscriptJul 22, 2019€37.28 (+5.52%)Earnings
- Q1 2019 Koninklijke Philips NV Earnings Call TranscriptApr 29, 2019Earnings
Koninklijke Philips NV to Discuss Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript
Thank you, and good morning, everyone. Welcome to today's conference call to update you on the Philips Respironics test and research program for the polyester polyurethane sound abatement foam. We appreciate that you could join our call on short notice. I'm here with our CEO, Roy Jakobs; our CFO, Abhijit Bhattacharya; and Steve Klink, who is the spokesperson for the test and research program. The press release, slide deck, infographic and frequently asked questions on the topic were published at 8:00 a.m. CET on our Investor Relations website this morning. The full transcript of this call will be made available on the website as well. Over to you, Roy.
Hello, everyone, and thank you for joining us this morning. Today, we are providing an update on the latest testing results regarding the safety of the sleep therapy devices and ventilators affected by the June 2021 field safety notice. Before I discuss the results in more detail, I would like to reiterate how important
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)